


Vol 89, No 10 (2024)
Articles
On the 100th Anniversary of the Birth of Academician Temirbolat T. Berezov



Combined Administration of Metformin and Amprolium to Rats Affects Metabolism of Free Amino Acids in the Brain, Altering Behavior, and Heart Rate
Abstract
The risk of developing diabetes and cardiometabolic disorders is associated with increased levels of alpha-aminoadipic acid and disturbances in the metabolism of branched-chain amino acids. The side effects of the widely used antidiabetic drug metformin include impaired degradation of branched-chain amino acids and inhibition of intracellular thiamin transport. These effects may be interconnected, as thiamine deficiency impairs the functioning of thiamine diphosphate (ThDP)-dependent dehydrogenases of 2-oxo acids involved in amino acids degradation, while diabetes is often associated with perturbed thiamine status. In this work, we investigate the action of metformin in rats with impaired thiamine availability. The reduction in the thiamine influx is induced by simultaneous administration of the thiamine transporters inhibitors metformin and amprolium. After 24 days of combined metformin/amprolium administration, no significant changes in the total brain levels of ThDP or activities of ThDP-dependent enzymes of central metabolism are observed, but the affinities of transketolase and 2-oxoglutarate dehydrogenase to ThDP increase. The treatment also significantly elevates the brain levels of free amino acids and ammonia, reduces the antioxidant defense, and alters the sympathetic/parasympathetic regulation, which is evident from changes in the ECG and behavioral parameters. Strong positive correlations between brain ThDP levels and contents of ammonia, glutathione disulfide, alpha-aminoadipate, glycine, citrulline, and ethanolamine are observed in the metformin/amprolium-treated rats, but not in the control animals. Analysis of the obtained data points to a switch in the metabolic impact of ThDP from the antioxidant and nitrogen-sparing in the control rats to the pro-oxidant and hyperammonemic in the metformin/amprolium-treated rats. As a result, metformin administration along with the amprolium-reduced thiamine supply significantly perturb the metabolism of amino acids in the rat brain, altering behavioral and ECG parameters.



Amino Acid Transport in the Rat Placenta in Methionine-Induced Hyperhomocysteinemia
Abstract
Maternal hyperhomocysteinemia (HHcy) is a risk factor for the development of intrauterine growth restriction, a proposed mechanism of which is a decrease in transplacental nutrient transport. In this study, we have investigated the effect of experimental HHcy caused by daily methionine administration to pregnant rats on the free amino acid content in the mother and fetal blood. The morphological and biochemical parameters on which amino acid transport through the placenta depends have also been studied. Under the influence of HHcy on the 20th day of pregnancy, an increase in the levels of most free amino acids was observed in the mother blood, while some amino acid concentrations in the fetal blood were decreased. Under conditions of HHcy in the placental labyrinth, which is an exchange site between mother and fetal circulations, the maternal sinusoids narrowed, being accompanied by blood stagnation and red blood cell aggregation. In the labyrinth zone, we also observed an increase in the protein level of neutral amino acid transporters (LAT1, SNAT2) and an activation of the downstream effector of the mTORC1 complex, 4E-BP1, which is a positive regulator of the placental transporter expression. Maternal HHcy caused an increase in the placental barrier permeability, as evidenced by an intensification in the mother to fetus transfer of the Evans blue dye. The imbalance of the free amino acid levels in the mother and fetal blood under conditions of HHcy may be due to the competition of homocysteine with other amino acids for their common transporters, as well as a decreased exchange zone area and reduced blood flow in the placental labyrinth. An increase in the amino acid transporter expression in the labyrinth zone may be a compensatory response to an insufficient intrauterine amino acid supply and a fetal growth decrease.



Bacterial Cellulose and Chitosan Composite for Prolonged Action of L-Asparaginase on Melanoma Cells
Abstract
A significant challenge associated with the therapeutic use of L-ASNase for the treatment of tumors is its rapid clearance from plasma. The effectiveness of L-ASNase is limited by dose-dependent toxicity. Therefore, new approaches are being developed for L-ASNase to improve its therapeutic properties. One of the approaches to enhance the properties of enzymes, including L-ASNase, is immobilization on various types of biocompatible polymers. The immobilization of enzymes on a carrier allows for the improvement of enzyme stability and the alteration of enzymatic activity duration. Bacterial cellulose (BC) is a promising carrier for various drugs due to its biocompatibility, non-toxicity, high porosity, and high drug loading capacity. Therefore, this material has a high potential for application in biomedicine. Native BC is known to have a number of disadvantages related to structural stability, which has led to the consideration of modified BC as a potential carrier for the immobilization of various proteins, including L-ASNase. In our study, a BC-chitosan composite in which chitosan is cross-linked with glutaraldehyde was proposed for the immobilization of L-ASNase. The physicochemical characteristics of BC-chitosan films were found to be superior to those of native BC films, resulting in an increase in the release time of L-ASNase in vitro from 8 to 24 hours and from 2 to 10 hours in a melanoma cell line upon transfer. Consequently, chitosan-modified BC films exhibit an augmented duration of cytotoxic action of immobilized L-ASNase on melanoma tumor cells in comparison to BC. This effect is associated with a transformation in the structure of BC due to cross-links between chitosan, which altered the physicochemical properties of BC.



Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism
Abstract
Glutamine plays an important role in tumor metabolism. It is known that the core region of the solid tumors is deprived of glutamine which affects tumor growth and spread. Here we investigated the effect of glutamine deprivation on cellular metabolism and sensitivity of human glioblastoma cells U87MG and T98G to drugs of various origin: alkylating cytostatic agent temozolomide; cytokine TRAIL DR5-B – agonist of the DR5 receptor; and GMX1778 – a targeted inhibitor of the enzyme nicotinamide phosphoribosyltransferase (NAMPT), limiting NAD biosynthesis. Bioinformatics analysis of the cell transcriptomes showed that U87MG cells have a more differentiated phenotype than T98G, and also differ in the expression profile of genes associated with glutamine metabolism. Upon glutamine deprivation, the growth rate of U87MG and T98G cells decreased. Analysis of cellular metabolism by FLIM microscopy of NADH as well as assessment of the lactate content in the medium showed that glutamine deprivation shifted the metabolic status of U87MG cells towards glycolysis. This was accompanied by an increase in the expression of the stemness marker CD133, which collectively may indicate the de-differentiation of these cells. At the same time, we observed an increase in both the expression of DR5 receptor and the sensitivity of U87MG cells to DR5-B. On the contrary, glutamine deprivation of T98G cells induced a metabolic shift towards oxidative phosphorylation, a decrease in DR5 expression and resistance to DR5-B. The effects of NAMPT inhibition also differed across two cell lines and were opposite to those of DR5-B: upon glutamine deprivation, U87MG cells acquired resistance, while T98G cells were sensitized to GMX1778. Thus, phenotypic and metabolic differences between two human glioblastoma cell lines resulted in divergent metabolic changes and contrasting responses to different targeted drugs during glutamine deprivation. These data should be considered when developing treatment strategies for glioblastoma via drug deprivation of amino acids, as well as when exploring novel therapeutic targets.



Regular articles
Myogenic Classical Endocannabinoids, Their Targets and Activity
Abstract
This review focuses on the recently discovered specific action of two classical endocannabinoids (EC), 2-arachidonoylglycerol (2-AG) and arachidonoylethanolamide (AEA), in the case of their synthesis and degradation in skeletal muscles, in other words this review is dedicated to the properties and action of the myoendocannabinoid (myoEC) pool. The influence of this pool is considered at three different levels: at the level of skeletal muscles, motor synapses, and also at the level of the whole organism, including the central nervous system. Special attention is paid to the still significantly underestimated and intriguing ability of ECs to have a positive effect on energy exchange and contractile activity of muscle fibers, as well as on transmitter secretion in motor synapses. The role of muscle contractions in the regulation of the activity balance of synthesis and degradation enzymes for myoECs and therefore in the release of myoECs and the exertion of their specific effects is thoroughly considered. Increasingly popular hypotheses about the prominent role of myoECs (AEA and/or 2-AG) in the rise of the overall level of ECs in the blood during muscle exercise and the development of “runner’s high” and about the role of myoECs in the correction of a number of psychophysiological conditions (pain syndrome, stress, etc.) are discussed here. Thus, this review presents information about the myoEC pool from a totally new viewpoint, underlining its possible independent and non-trivial regulatory role in the body, in contrast to the traditional and well-known activity of neurogenic ECs.



Analysis of the Expression of the GRIPAP1, DLG4, KIF1B, NGFRAP1 and NRF1 Genes in the Peripheral Blood of Patients with Parkinson’s Disease in the Early Clinical Stages
Abstract
Parkinson’s disease (PD) is one of the most common progressive neurodegenerative diseases. An important feature of the disease is its long latent period, which necessitates the search for prognostic biomarkers. One method of identifying biomarkers of PD is to study changes in gene expression in the peripheral blood of patients who are at an early stage of the disease and have not been treated. In this study, we analyzed the relative levels of mRNA for the genes GRIPAP1, DLG4, KIF1B, NGFRAP1, and NRF1, which are associated with neurotransmitter transport, apoptosis and mitochondrial dysfunction, in the peripheral blood of PD patients using reverse transcription and real-time PCR with TaqMan probes. The results of this study suggest that the GRIPAP1 and DLG4 genes can be considered as potential biomarkers for the early clinical stages of Parkinson’s disease. The data obtained may indicate that NGFRAP1 is involved in the pathogenesis of both PD and other neurodegenerative diseases. Furthermore, at the early clinical stages we studied, the KIF1B and NRF1 genes were not found to be involved in the pathogenesis of PD at the expression level.



Comparative Study of Spectral and Functional Properties of Reaction Centers of Wild Type and Double Mutant H(L173)L/I(L177)H of the Purple Bacterium Cereibacter sphaeroides
Abstract
Previously, we found that in the reaction center (RC) of the purple bacterium Cereibacter sphaeroides, the formation of a heterodimeric primary electron donor (P), caused by the substitution of His-L173 by Leu, was compensated by a second mutation Ile-L177 – His. Significant changes in the spectral properties, pigment composition and redox potential of P, observed in the H(L173)L RC, are restored to the corresponding characteristics of the native RC in the RC H(L173)L/I(L177)H, with the difference that the energy of the long-wavelength QY optical transition of P increases significantly (by ~75 meV). In this work, using light-induced FTIR difference spectroscopy, it was shown that in the RC with double mutation, the homodimeric structure of P is preserved with partially altered electronic properties: the electronic coupling in the radical-cation of the P+ dimer is weakened and the localization of the positive charge on one of its halves increases. The results of the study of the triple mutant H(L173)L/I(L177)H/F(M197)H are consistent with the assumption that the observed changes in the P+ electronic structure, as well as considerable blue shift of QY P absorption band in the RC H(L173)L/ I(L177)H, are associated with a modification of the spatial position and/or geometry of P. Using femtosecond absorption difference spectroscopy, it was shown that the mutant H(L173)L/I(L177)H RC retains a sequence of reactions P* → P+BA− → P+HA− → P+QA− with electron transfer rates and the quantum yield of the final state P+QA− close to those observed in the wild-type RC (P* is the singlet-excited state of P; BA, HA, and QA are molecules of bacteriochlorophyll, bacteriopheophytin, and ubiquinone in the active A-branch of cofactors, respectively). The obtained results, together with previously published data for the RC with a symmetrical double mutation H(M202)L/I(M206)H, demonstrate that by introducing additional point amino acid substitutions, the photochemical activity of the isolated RC from C. sphaeroides can be maintained at a high level even in the absence of important structural elements – axial histidine ligands to the primary electron donor P.



Astaxanthin Reduces Н2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Cardiomyocyte Cells
Abstract
Cardiovascular diseases are one of the most challenging problems in clinical practice. Astaxanthin (AST) is a keto-carotenoid (xanthophyll) mainly of marine origin, which is able to penetrate the cell membrane, localize in the mitochondria and prevent mitochondrial dysfunction. The present study examined the effect of astaxanthin on the death of H9c2 cardiomyocytes caused by the cytotoxic effect of hydrogen peroxide (H2O2) and doxorubicin. Using the methods of spectrophotometry, spectrofluorimetry, and Western blotting analysis, it was shown that treatment of cells with AST contributed to an increase in the number of H9c2 cells resistant to H2O2 and doxorubicin, while maintaining the value of their mitochondrial transmembrane potential, reducing the intracellular production of reactive oxygen species and an increase in the intracellular content of mitophagy markers PINK1, Parkin and prohibitin 2. The obtained results suggest that the use of AST may be a highly effective way to prevent and treat cardiovascular diseases.



Li+ Ions Accumulation Triggers FOS, JUN, EGR1, MYC Transcription Alteration in LiCl-Treated Human Umbilical Vein Endothelial Cells (HUVEC)
Abstract
Changes in the intracellular concentrations of Na+ and K+ are shown to alter gene expression. Another monovalent cation, Li+, is well known as medicine for the treatment of psychiatric disorders but mechanism of its action is obscure. Thus, it is important to evaluate an effect of Li+ on gene expression in endothelial cells. Here we studied the influence of increased intracellular Na+ or Li+ concentrations on the transcription of Na+i/K+i-sensitive genes. A treatment of human endothelial cells (HUVEC) with LiCl for 1.5 h caused an accumulation of Li+ in the cells. This was followed by an increase in FOS and EGR1 mRNA and a decrease in JUN and MYC mRNA levels. Treatment of HUVEC with monensin led to an accumulation of Na+ and a loss of K+ ions. However, Na+-ionophore monensin had no significant effect on gene expression. Incubation of HUVEC with elevated extracellular NaCl concentration increased intracellular K+ concentration and ATF3 transcription and decreased JUN transcription. These results indicate that Na+ and Li+ ions have different effects on the cellular gene expression profile that apparently due to various actions on the intracellular monovalent cations ratio.



Kinetics of Electron Transfer between Redox Cofactors in Photosystem I Measured by High-Frequency EPR Spectroscopy
Abstract
Using high-frequency pulsed EPR spectroscopy in the Q range at cryogenic temperatures, the kinetics of redox transformations of the primary electron donor and the quinone acceptor in various complexes of photosystem I (PSI) from the cyanobacterium Synechocystis sp. PCC 6803 were simultaneously studied for the first time in the time range of 200 μs-10 ms. In the A1-core complexes of PSI that lack 4Fe4S clusters, the kinetics of the and signals decay at a temperature of 100 K coincided and had a characteristic time of τ ≈ 500 μs, caused by charge recombination in the A ion-radical pair in the A branch of redox cofactors. The kinetics of the reverse electron transfer from B to in the B branch of redox cofactors with τ < 100 μs could not be recorded due to the time limitations of the method. In the native PSI complexes comprising a full set of redox cofactors and in the FX-core complexes with the 4Fe4S cluster FX only the kinetics of the signal was significantly faster than that of the signal. The disappearance of the signal had a characteristic time of 280-350 μs. It was suggested that, in addition to the reverse electron transfer from A to with τ ≈ 500 μs, it also includes a slowed down (up to 150-200 μs) forward electron transfer from A to the 4Fe4S cluster FX. In the kinetics of reduction, it was possible to distinguish components caused by the reverse electron transfer from (τ ≈ 500 μs) and from 4Fe4S clusters (τ = 1 ms for the FX-core and τ > 5 ms for native complexes). These results are in qualitative agreement with the data on the kinetics of reduction obtained earlier using pulsed absorption spectrometry at cryogenic temperatures.


